489 related articles for article (PubMed ID: 16424051)
1. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.
Zerbini A; Pilli M; Penna A; Pelosi G; Schianchi C; Molinari A; Schivazappa S; Zibera C; Fagnoni FF; Ferrari C; Missale G
Cancer Res; 2006 Jan; 66(2):1139-46. PubMed ID: 16424051
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response.
Zerbini A; Pilli M; Laccabue D; Pelosi G; Molinari A; Negri E; Cerioni S; Fagnoni F; Soliani P; Ferrari C; Missale G
Gastroenterology; 2010 May; 138(5):1931-42. PubMed ID: 20060829
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma.
Mizukoshi E; Yamashita T; Arai K; Sunagozaka H; Ueda T; Arihara F; Kagaya T; Yamashita T; Fushimi K; Kaneko S
Hepatology; 2013 Apr; 57(4):1448-57. PubMed ID: 23174905
[TBL] [Abstract][Full Text] [Related]
4. Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation.
Zerbini A; Pilli M; Fagnoni F; Pelosi G; Pizzi MG; Schivazappa S; Laccabue D; Cavallo C; Schianchi C; Ferrari C; Missale G
J Immunother; 2008 Apr; 31(3):271-82. PubMed ID: 18317360
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes.
Nobuoka D; Motomura Y; Shirakawa H; Yoshikawa T; Kuronuma T; Takahashi M; Nakachi K; Ishii H; Furuse J; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kinoshita T; Komori H; Baba H; Fujiwara T; Nakatsura T
Int J Oncol; 2012 Jan; 40(1):63-70. PubMed ID: 21922136
[TBL] [Abstract][Full Text] [Related]
6. RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients.
Napoletano C; Taurino F; Biffoni M; De Majo A; Coscarella G; Bellati F; Rahimi H; Pauselli S; Pellicciotta I; Burchell JM; Gaspari LA; Ercoli L; Rossi P; Rughetti A
Int J Oncol; 2008 Feb; 32(2):481-90. PubMed ID: 18202772
[TBL] [Abstract][Full Text] [Related]
7. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
8. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357
[TBL] [Abstract][Full Text] [Related]
10. Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits.
Wissniowski TT; Hänsler J; Neureiter D; Frieser M; Schaber S; Esslinger B; Voll R; Strobel D; Hahn EG; Schuppan D
Cancer Res; 2003 Oct; 63(19):6496-500. PubMed ID: 14559842
[TBL] [Abstract][Full Text] [Related]
11. Activation of dendritic cells by local ablation of hepatocellular carcinoma.
Ali MY; Grimm CF; Ritter M; Mohr L; Allgaier HP; Weth R; Bocher WO; Endrulat K; Blum HE; Geissler M
J Hepatol; 2005 Nov; 43(5):817-22. PubMed ID: 16087270
[TBL] [Abstract][Full Text] [Related]
12. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC Chemokine ligand 3/macrophage inflammatory protein-1alpha.
Iida N; Nakamoto Y; Baba T; Nakagawa H; Mizukoshi E; Naito M; Mukaida N; Kaneko S
Cancer Res; 2010 Aug; 70(16):6556-65. PubMed ID: 20663902
[TBL] [Abstract][Full Text] [Related]
14. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
15. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
[TBL] [Abstract][Full Text] [Related]
16. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S
Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
[TBL] [Abstract][Full Text] [Related]
18. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
[TBL] [Abstract][Full Text] [Related]
19. [Radiofrequency ablation for hepatocellular carcinoma and liver metastases].
Yasumoto T; Murakami T; Katsumoto Y; Hashimoto T; Noda S; Murata K; Kinuta M; Nakamura H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1596-9. PubMed ID: 16315881
[TBL] [Abstract][Full Text] [Related]
20. Modulation of blood circulating immune cells by radiofrequency tumor ablation.
Rughetti A; Rahimi H; Rossi P; Frati L; Nuti M; Gaspari A; Danza FM; Ercoli L
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):247-50. PubMed ID: 16767940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]